Dr Sarah Rawlings, Head of Policy & Involvement at Breakthrough Breast Cancer, says: "This is very early research that has only been carried out in mice so we don't actually know if it could be used in women. Much more research is needed to find out if it works, to either treat HER2 positive breast cancer or prevent the disease, and if there are any side effects.
More...
Linear Mode
